Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2024-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$215.8m
reported value
+45.4% vs Q2 2024
36positions
76.0%in top 10
2 new
4 added
6 reduced
1 sold out
vs Q2 2024
Holdings, Q3 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APPLIED THERAPEUTICS INC APLT | $47.4m21.96% | Unchanged |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $35.5m16.45% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $29.5m13.68% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $8.8m4.09% | Reduced -39.0k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $7.9m3.65% | Unchanged |
| SPDR GOLD TR GLD | $7.8m3.60% | Unchanged |
| ENTERA BIO LTD ENTX | $7.4m3.42% | Unchanged |
| HOOKIPA PHARMA INC COM | $7.2m3.33% | Reduced -5.0m |
| ALTIMMUNE INC ALT | $6.9m3.19% | Unchanged |
| VERONA PHARMA PLC VRNA | $5.8m2.67% | Unchanged |
| SEABRIDGE GOLD INC COM | $5.3m2.47% | Added +70.4k |
| OCULAR THERAPEUTIX INC OCUL | $5.2m2.42% | Added +400.0k |
| MEIRAGTX HLDGS PLC MGTX | $5.2m2.42% | New |
| AGNICO EAGLE MINES LTD AEM | $4.5m2.07% | Unchanged |
| KINROSS GOLD CORP KGC | $4.1m1.91% | Unchanged |
| EQUINOX GOLD CORP EQX | $3.4m1.55% | Unchanged |
| FRANCO NEV CORP FNV | $3.1m1.44% | Unchanged |
| SKEENA RES LTD NEW SKE | $2.7m1.24% | Added +276.6k |
| MAG SILVER CORP MAG | $2.4m1.11% | Reduced -105.0k |
| ISHARES SILVER TR SLV | $2.3m1.05% | Added +31.5k |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $2.1m0.98% | Unchanged |
| VISA INC V | $1.3m0.62% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.2m0.56% | Unchanged |
| ISHARES TR ITA | $1.1m0.53% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.1m0.53% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $1.1m0.50% | Unchanged |
| ROYAL GOLD INC RGLD | $1.1m0.49% | Unchanged |
| DIAGEO PLC DEO | $947.3k0.44% | Unchanged |
| CVS HEALTH CORP CVS | $911.8k0.42% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $763.5k0.35% | Reduced -47.5k |
| NEW PAC METALS CORP NEWP | $722.6k0.33% | Unchanged |
| SILVERCREST METALS INC SIL | $555.0k0.26% | Reduced -410.0k |
| Orgenesis, Inc. COM | $283.1k0.13% | Reduced -571.3k |
| CARDIOL THERAPEUTICS INC CRDL | $198.0k0.09% | Unchanged |
| OPUS GENETICS INC IRD | $131.0k0.06% | Unchanged |
| GRAIL INC GRAL | $1.4k0.00% | New |
Sold out since Q2 2024
| Security | Value then |
|---|---|
| GLOBAL X FDS SIL | $1.4m45.2k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |